Current state and future prospects of off-the-shelf allogeneic CAR NK therapy
Rinsho Ketsueki. 2024;65(7):668-675. doi: 10.11406/rinketsu.65.668. ABSTRACT Chimeric antigen receptor-transduced autologous T (CAR-T) cell therapy targeting CD19 has revolutionized the treatment of CD19-positive hematological tumors, including …